Prostate cancer presents challenges in detection, treatment, and management. Learn about genetic risks, treatment resistance, ...

Bruce Cozadd, the retiring CEO of Jazz Pharmaceuticals, has outlined a developing oncology pipeline at the company. Speaking ...

The Perlmutter Cancer Center at New York City-based NYU Langone Health recently launched its new Center for Molecular Oncology, naming Shridar Ganesan, MD, PhD, as director. The center will manage, ...

An American Society of Radiation Oncology survey has shined a spotlight on the impact prior authorization has on providers ...

Nearly half of all new cancer drugs approved by the U.S. Food and Drug Administration (FDA) over the past quarter-century ...

At my routine oncology checkup, I regretted not bringing my husband when an unexpected medication changes left me feeling ...

CEO Albert Bourla expressed modest optimism for Pfizer’s 2025 revenues at JPM 2025, supported by plans to prioritize R&D in ...

The most important take-home information from the INTERLACE trial is that in some people with cervical cancer that are ...

The one-and-a-half-day symposium provides an overview of recent advances in the treatment of solid tumors with novel targeted ...

NDAQ:WINT) Windtree Strengthens Global Intellectual Property Portfolio with New Japanese Patent For the Company's Oncology ...

Combination creates immediate scientific synergies by harnessing complementary AI / ML platforms to improve patient outcomes across multiple ...

BMO Capital analyst Evan Seigerman has maintained their neutral stance on MRK stock, giving a Hold rating on January 10.Stay Ahead of the ...